Pharminox appoints Marc Hummersone as Head of Chemistry
Nottingham, UK, 15 April 2008 - Pharminox Limited ("Pharminox" or "the Company"), the private UK cancer R&D company, today announced that it has appointed Dr Marc Hummersone PhD as Head of Chemistry.
Dr Hummersone was formerly a Chemistry Group Leader at KuDOS Pharmaceuticals, the private oncology company acquired by AstraZeneca plc in 2006. In his new position he will take over the day to day management of Pharminox's chemistry programmes reporting to Malcolm Stevens OBE, the Company's Chief Scientific Officer.
Commmenting on today's announcement, Peter Worrall Cheif Executive of Pharminox said, "This is a key appointment for Pharminox. One of the the Company's core skills is in medicinal chemistry so we are delighted to have attracted someone of Marc's calibre. He is a very experienced chemist with highly relevant expertise in small-molecule cancer chemistry through his previous role at KuDOS."